Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Sanofi

Top 3 Pharma Innovators to Watch Closely

The pharmaceutical industry is experiencing considerable growth, driven by rising healthcare needs, continuous advances in drug discovery & discovery, and M&A activity. So, investors could keep a close eye on top pharma stocks Amneal Pharmaceuticals (AMRX), Collegium Pharmaceutical (COLL), and Sanofi (SNY) for potential gains. Keep reading….

StockNews.com

Navigate to Success With These 4 Pharma Stocks to Buy

The pharmaceutical industry is expanding due to increased demand for healthcare products and technological advancements. Therefore, fundamentally strong pharma stocks Kamada (KMDA), Hypera (HYPMY), Eli Lilly (LLY) and Sanofi (SNY) might be ideal additions to your portfolio. Read on.

StockNews.com

4 Sky-Rocketing Pharma Stocks to Watch

The pharmaceutical industry is experiencing significant growth due to the rising demand for quality healthcare and high-quality drugs. This surge is further supported by the rapid growth in the global elderly population and the increase in chronic illnesses. Therefore, investors could consider adding pharma stocks Spero Therapeutics (SPRO), Wave Life…

StockNews.com

From analysis to the latest developments in health,
read the most diverse news in one place.

The mothers fighting a scandal bigger than thalidomide: ‘We were told the medication was safe’

Since the 1970s, it has been known that sodium valproate can harm babies in the womb. So why was it prescribed to pregnant women?

The Guardian - UK

5 Pharma Stocks to Watch With Bullish Momentum

The pharma industry is poised for robust expansion this year with rising demand and technological advancement in the sector. Hence, investors might watch fundamentally solid pharma stocks Procaps Group (PROC), Sanofi (SNY), Viatris (VTRS), Ipsen (IPSEY), and Teva Pharmaceutical Industries (TEVA) for solid gains. Read on.

StockNews.com

3 B-Rated Pharma Stocks to Secure Now With Great Value

The pharmaceutical industry, which experienced significant growth over the past years, is anticipated to remain buoyed, driven by the increasing prevalence of chronic diseases, advancements in medical technology, and rising healthcare awareness and expenditure. Given this backdrop, quality pharma stocks Voyager Therapeutics (VYGR), Sanofi (SNY), and Pacira BioSciences (PCRX), with…

StockNews.com

Gen X drugmaker is coughing up millions for Paris Olympics sponsorship to show Gen Z and millennials it's a cool place to work

Sanofi is hoping the exposure will help put the brand in front of prospective young talent which it has struggled to recruit.

Fortune

Read news from The Economist, FT, and more,
with one subscription

Insulin Now Available for $35 a Month for Many Americans

Insulin price caps from Eli Lilly, Novo Nordisk and Sanofi take effect this month.

Kiplinger

Insulin prices to drop after manufacturers cap costs

Good news for Americans with diabetes as Sanofi becomes the third major insulin manufacturer to cap costs at per month, reducing financial strain and i...

Top News

Pharmaceutical plant found to have leaked neurotoxin in south-western France

A Sanofi pharmaceutical plant in the south west of France has been found to have discharged large quantities of the bromopropane neurotoxin into the atmosphere in mid-November.

Radio France Internationale

How the high-stakes world of Formula 1 racing inspired Sanofi CEO Paul Hudson to deliver more medicines

Hudson sought to emulate the efficiency of a race car team that recently set the world record for quickest pit stop.

Fortune

RSV drug shortage prompts CDC to adjust recommendations

A new antibody shot called Beyfortus was recently approved to protect babies from RSV, but it's in short supply this season.

LiveScience

Sanofi and Insight Enterprises CEOs: How AI can empower workers and turn big companies into nimble ones

Sanofi CEO Paul Hudson and Insight CEO Joyce Mullen say that for leaders who integrate AI mindfully, 'the resulting force will be unrivaled.'

Fortune

3 Pharma Stocks on the Rise - Buy Now

The pharmaceutical industry is well-positioned for long-term growth thanks to rising investments in drug development and technological advancements. Thus, it would be prudent to buy pharma stocks, Sanofi (SNY), Johnson & Johnson (JNJ) and AstraZeneca PLC (AZN). Read on.

StockNews.com

Get all your
news in one place.

100’s of premium titles.
One news app.

WEKU

A new RSV shot could help protect babies this winter — if they can get it in time

Hospitals were overwhelmed last winter by a surge in pediatric cases of RSV. Now a new monoclonal antibody shot could help, but price and supply issues are causing delays in getting it to infants.

The Independent UK

A new RSV shot for infants is in short supply

A new shot for infants against RSV is in short supply, and U.S. health officials are telling doctors they should prioritize giving the drug to babies at the highest risk of severe disease

StockNews.com

3 Pharma Stocks to Buy Now for a Dose of Profit

The pharmaceutical sector is expanding due to advanced technologies such as AI and new drug discoveries. Hence, quality pharma stocks GoodRx Holdings (GDRX), Merck & Co. (MRK), and Sanofi (SNY) might be profitable investments right now. Read on.

StockNews.com

3 Pharma Stocks Investors Are Chasing for Value

With the advent of advanced medications and the increasing need for personalized treatments, the pharmaceutical industry looks well-poised for long-term growth. Therefore, it could be worth looking into three fundamentally sound pharma stocks, Pfizer (PFE), Sanofi (SNY), and GSK plc (GSK), that are offering significant value. Read more….

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

New drug to protect babies and toddlers from RSV gets FDA approval ahead of cold season

U.S. officials have approved a new long-acting drug to protect babies and toddlers against a respiratory virus that causes thousands of hospitalizations each year

The Guardian - UK

Revealed: pharma giants pour millions of pounds into NHS to boost drug sales

Observer investigation raises concerns about the influence of drugs companies in shaping patient care in services that use their products

Zenger

Gary Vee, Kevin Durant, Alex Rodriguez Backed Tracer Land New Investors

Data intelligence platform, Tracer, announced a new president to lead the company

Fortune

Gen Z needs brand-new skills to climb to the C-suite, says healthcare CEO

Knowing how to use and implement generative A.I. will be a “minimum expectation” for future CEOs, Sanofi CEO Paul Hudson said.

The Hindu

U.S. firm StemCures to set up manufacturing lab in Telangana

StemCures, a medical clinic in Ohio focused on stem cell therapy, will be establishing a manufacturing lab in Telangana with around $54 million investment and employment potential for around 150 people.

Fortune

Sanofi CEO: ‘Europe’s lead in life sciences R&D is eroding–but co-localized hubs could allow it to keep up’

'Innovation is powered by more than just money,' writes Sanofi CEO Paul Hudson.

Evening Standard

Autumn Covid booster 2023: Who is eligible for another jab?

If invited, you will receive a booster dose of a Covid-19 vaccine made by Pfizer, Moderna, or Sanofi

1 … 3 4 5 6

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.